Dufau M L, Podesta E J, Catt K J
Proc Natl Acad Sci U S A. 1975 Apr;72(4):1272-5. doi: 10.1073/pnas.72.4.1272.
The physical properties of detergent-solubilized gonadotropin receptor-hormone complexes, determined by density gradient centrifugation and gel filtration, were compared after in vivo and in vitro labeling of specific ovarian binding sites with radioiodinated human chorionic gonadotropin (hCG). Following intravenous administration of biologically active 125I-labeled hCG, up to 50% of the gonadotropin tracer was bound to the luteinized ovaries of immature female rats treated with pregnant mare serum/human chorionic gonadotropin. Comparable binding of 125I-labeled hCG was observed after equilibration of ovarian particles with the labeled hormone in vitro. The sedimentation properties of the solubilized receptor-hormone complexes formed in vivo were identical with those derived for the corresponding complexes formed in vitro and extracted with Triton X-100 and Lubrol PX, with sedimentation constants of 8.8 S for the Triton-solubilized complex and 7.0 S for the complex extracted with Lubrol PX. During analytical gel filtration of the Triton-solubilized receptor-hormone complex on Sepharose 6B in 0.1% Triton X-100, the partition coefficient (Kav) of the "in vivo" complex (0.32) was not significantly different from that of the complex formed in vitro (0.29). Gel filtration of the Lubrol-solubilized ovarian particles on Sepharose 6B in 0.5% Lubrol PX gave Kav values for the "in vivo" and "in vitro" labeled complexes of 0.36 and 0.32, respectively. These findings demonstrate that the physical properties of size and shape which determine the partition coefficient and sedimentation characteristics of detergent-solubilized gonadotropin receptor-hormone complexes formed in vitro are not distinguishable from those of the complexes extracted after specific interaction of the ovarian gonadotropin receptors with radioiodinated hCG in vivo.
在用放射性碘化人绒毛膜促性腺激素(hCG)对特定卵巢结合位点进行体内和体外标记后,通过密度梯度离心和凝胶过滤法测定了去污剂增溶的促性腺激素受体 - 激素复合物的物理性质。静脉注射具有生物活性的125I标记的hCG后,高达50%的促性腺激素示踪剂与用孕马血清/人绒毛膜促性腺激素处理的未成熟雌性大鼠的黄体化卵巢结合。在体外将卵巢颗粒与标记激素平衡后,观察到125I标记的hCG具有类似的结合情况。体内形成的增溶受体 - 激素复合物的沉降特性与体外形成并用Triton X - 100和Lubrol PX提取的相应复合物相同,Triton增溶复合物的沉降常数为8.8 S,Lubrol PX提取的复合物沉降常数为7.0 S。在0.1% Triton X - 100中于Sepharose 6B上对Triton增溶的受体 - 激素复合物进行分析性凝胶过滤时,“体内”复合物的分配系数(Kav)(0.32)与体外形成的复合物(0.29)无显著差异。在0.5% Lubrol PX中于Sepharose 6B上对Lubrol增溶的卵巢颗粒进行凝胶过滤时,“体内 ”和“体外”标记复合物的Kav值分别为0.36和0.32。这些发现表明,在体外形成的去污剂增溶的促性腺激素受体 - 激素复合物的大小和形状的物理性质,与卵巢促性腺激素受体在体内与放射性碘化hCG特异性相互作用后提取的复合物的这些性质没有区别,这些性质决定了分配系数和沉降特性。